Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2005-08-30
2005-08-30
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S532000, C514S529000, C514S569000, C514S561000, C514S562000, C514S568000, C514S534000, C560S038000, C560S039000, C560S010000, C560S103000, C560S104000, C560S056000, C562S466000, C562S435000, C562S492000, C562S427000, C562S493000, C562S495000
Reexamination Certificate
active
06936636
ABSTRACT:
Compounds of the formula:where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of reducing serum thyroxine levels and transiently increasing triglyceride levels.
REFERENCES:
patent: 4980369 (1990-12-01), Chandraratna
patent: 5015658 (1991-05-01), Chandraratna
patent: 5023341 (1991-06-01), Chandraratna
patent: 5455265 (1995-10-01), Chandraratna
patent: 5675033 (1997-10-01), Vuligonda et al.
patent: 5917082 (1999-06-01), Vuligonda et al.
patent: 6034242 (2000-03-01), Vuligonda et al.
patent: 6048873 (2000-04-01), Vasudevan et al.
patent: 6114533 (2000-09-01), Vuligonda et al.
patent: 6147224 (2000-11-01), Vuligonda et al.
patent: 6403638 (2002-06-01), Vuligonda et al.
patent: WO 93/11755 (1993-06-01), None
Mangelsdorf et al.The Retinoids Receptors In: The Retinoids.,1994, p. 319-349. Raven Press, Ltd., New York.
Dawson et al.Chemistry and Biology of Synthetic Retinoids.(1990) p. 324-363. CRC Press Inc.
Mukherjee et al. “Sensitization of Diabetic and Obese Mice to Insulin by Retinoid X Receptor Agonists”,Nature,1997, p. 407-410, vol. 386.
Feigner P.L. et al. (1989) “Cationic Lipsome-Mediated Transfection”Focus,1989, p. 21-24, v.11-No. 2.
Heyman et al. “9-Cis Retinoic Acid Is a High Affinity Ligand for the Retinoid X Receptor”Cell,1992, vol. 68, p. 397-406.
Allegretto et al. “Transactivation Properties of Retinoic Acid and Retinoid X Receptors in Mammalian Cells and Yeast”J. Biol. Chem..1993, vol. 268, p. 26625-26633.
Cheng et al. Relationship Between the Inhibition Constant (K1) and the Concentration of Inhibitor which Causes 50 Per Cent Inhibition (I50) of an Enzymatic ReactionBiolochemical Pharmacology,1973, vol. 22, p. 3099-3108.
Bhat Smita
Chandraratna Roshantha A.
Sinha Santosh
Tsang Kwok Yin
Allergan Inc.
Owens Amelia A.
Szekeres Gabor L.
LandOfFree
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477941